Description
RADIOPHARMACEUTICALS
First action · last action
2008-10-01 · 2014-04-01
Transactions
10
First transaction's obligation
$535,860
Base + all options value (sum of deltas)
$3,567,575
Extent competed
FULL AND OPEN COMPETITION
Other than full & open authority
—
Set-aside
NO SET ASIDE USED.
Offers received
2
SDVOSB flag on record
No
NAICS
325412 · PHARMACEUTICAL PREPARATION MANUFACTURING
Modification chain · 10 transactions
Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.
- Base2008-10-01+$535,860= $535,860
- Mod 32009-11-24+$400,200= $936,060
- Mod 42010-10-01+$135,000= $1,071,060
- Mod 52011-10-01+$150,000= $1,221,060
- Mod 62012-10-01+$700,000= $1,921,060
- Mod P000102012-10-01-$105,401= $1,815,659
- Mod P000092013-10-01+$350,000= $2,165,659
- Mod P000122013-10-01-$67,024= $2,098,634
- Mod P000112014-04-01+$350,000= $2,448,634
- Mod P000132014-04-01+$160= $2,448,794
| Transaction | Action date | This action (delta) | Running total | Description on this transaction |
|---|---|---|---|---|
| Base | 2008-10-01 | +$535,860 | $535,860 | RADIOPHARMACEUTICALS |
| Mod 3· EXERCISE AN OPTION | 2009-11-24 | +$400,200 | $936,060 | RADIOPHARMACEUTICALS |
| Mod 4· EXERCISE AN OPTION | 2010-10-01 | +$135,000 | $1,071,060 | RADIOPHARMACEUTICALS |
| Mod 5· EXERCISE AN OPTION | 2011-10-01 | +$150,000 | $1,221,060 | RADIOPHARMACEUTICALS |
| Mod 6· EXERCISE AN OPTION | 2012-10-01 | +$700,000 | $1,921,060 | RADIOPHARMACEUTICALS |
| Mod P00010· EXERCISE AN OPTION | 2012-10-01 | −$105,401 | $1,815,659 | RADIOPHARMACEUTICALS |
| Mod P00009· EXERCISE AN OPTION | 2013-10-01 | +$350,000 | $2,165,659 | RADIOPHARMACEUTICALS |
| Mod P00012· EXERCISE AN OPTION | 2013-10-01 | −$67,024 | $2,098,634 | RADIOPHARMACEUTICALS |
| Mod P00011· EXERCISE AN OPTION | 2014-04-01 | +$350,000 | $2,448,634 | RADIOPHARMACEUTICALS |
| Mod P00013· EXERCISE AN OPTION | 2014-04-01 | +$160 | $2,448,794 | RADIOPHARMACEUTICALS |
Related awards · 11
Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.
Other VA awards to the same recipient (UEI CETPVZL5RQS3)
| Award | Office · PSC / listing | Net obligations | FY |
|---|---|---|---|
| 36C25926N0409 | NETWORK CONTRACT OFFICE 19 (36C259) · 6505 · DRUGS AND BIOLOGICALS | $34,735 | FY2026 |
| 36C24826N0693 | 248-NETWORK CONTRACT OFFICE 8 (36C248) · 6505 · DRUGS AND BIOLOGICALS | $111,150 | FY2026 |
| 36C25226N0456 | 252-NETWORK CONTRACT OFFICE 12 (36C252) · 6505 · DRUGS AND BIOLOGICALS | $34,735 | FY2026 |
| 36C26326F0080 | NETWORK CONTRACT OFFICE 23 (36C263) · 6505 · DRUGS AND BIOLOGICALS | $27,788 | FY2026 |
| 36C25726N0272 | 257-NETWORK CONTRACT OFFICE 17 (36C257) · 6505 · DRUGS AND BIOLOGICALS | $257,789 | FY2026 |
| 36C25726D0056 | 257-NETWORK CONTRACT OFFICE 17 (36C257) · 6505 · DRUGS AND BIOLOGICALS | $0 | FY2026 |
Other recipients under 6505 from 247-NETWORK CONTRACT OFFICE 7 (most recent first)
| Award | Recipient | Office | Net obligations | FY |
|---|---|---|---|---|
| VA24716F1310 | CSL BEHRING L.L.C. | 247-NETWORK CONTRACT OFFICE 7 | $4,216 | FY2016 |
| VA24716F1335 | CSL BEHRING L.L.C. | 247-NETWORK CONTRACT OFFICE 7 | $99,527 | FY2016 |
| VA24016E0162 | MCKESSON CORPORATION | 247-NETWORK CONTRACT OFFICE 7 | $13,321,179 | FY2016 |
| VA24716F1165 | CSL BEHRING L.L.C. | 247-NETWORK CONTRACT OFFICE 7 | $4,216 | FY2016 |
| VA24016E0119 | MCKESSON CORPORATION | 247-NETWORK CONTRACT OFFICE 7 | $15,214,900 | FY2016 |
Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_VA247P0718_3600_-NONE-_-NONE- · retrieved 2026-09-26.